Skip to content

DERMA-MED

Active Private limited companyfounded 2011active for 15 yearsManoir d'Anjoulaan 42, 1150 Woluwe-Saint-PierreKBO/BCE: BE 0832.863.378

Lifetime

15 annual accounts with figures on one time axis
peak of €120,335 in 2015
€58,051▲ 41.0%
lowest -€14,458 in 2011
€22,443▲ 94.1%
peak of €92,604 in 2015
€63,602▼ 24.0%
€70,959▲ 19.4%
Board1 name since 2011
1 director
Owners
  
Documentsfilings and deeds
03-07-202628 days before the deadline
2025micro format
Gross margin from €41,178 to €58,051Result from €11,565 to €22,443Dividend €42,574Equity from €83,733 to €63,602Debts from €59,427 to €70,959Cash from €4,954 to €30,566

Key points

from the 2025 annual accounts

Equity

€63,602 ▼ 24.0%
83,7332024+22,443Profit-42,574Dividend63,6022025

DERMA-MED paid out €42,574 in dividends. That is 190% of the 2025 profit.

Turnover

≈ €130,000 estimated

The micro format states no turnover.

Filings

15 annual accounts since 2011
AprilJune31 JulyOctober201520202025

Seven of the last ten came late. The 2016 accounts came in latest, 74 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,728 companies had the same profile as DERMA-MED has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,728 companies, not a prediction for DERMA-MED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 17-01-2011
  • 100%annual accounts 2017
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0832863378
appointed as sole director Legal-form conversion: from private limited company (pre-2019) to private limited company · Discharge granted to (manager) · General meeting of 21-12-2023 · Gazette deed
First establishment Clinique de l'Europe - Centre, De Frélaan 206, Uccle
All 24 events

Comparable companies

same main activity, similar in size and age
Company
DERMA-MED Woluwe-Saint-Pierre €134,562 €58,051 47.3% -
DERMATOLOGIE TAMARA DEVIS Berlare €138,410 €54,318 87.0% -
Dokter Annelore Dermauw Kortrijk €133,106 €53,614 51.8% -
MITITELU MEDICAL Wavre €120,918 €58,332 88.7% -
DR. CURTIS Lummen €130,816 €54,534 92.4% -
DR PHEANY OU Woluwe-Saint-Lambert €155,538 €75,574 48.1% -
JEROME ROUSSEAUX Namur €126,147 €67,003 41.6% -

These companies have the same main activity as DERMA-MED: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €121,000 and €156,000, founded between 2008 and 2011.

Official details

Source: KBO
Status
Active since 17-01-2011Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment units
2.302.260.4551180 Uccle, since 01-10-2015
2.302.260.8511150 Woluwe-Saint-Pierre, since 17-05-2017
Financial year end
31 December
Peppol
Reachable since 19-12-2025
Company details

Annual accounts 2025

€134,562▼ 6.0%
Filing
Filed on 03-07-2026, 28 days before the end of the filing period
Financials

Insights on DERMA-MED

DERMA-MED files the micro format. That format states no turnover. The gross margin fell from €61,830 in 2011 to €58,051 in 2025.

The balance sheet grew most in 2021 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DERMA-MED

What is the company number of DERMA-MED?
The company number of DERMA-MED is 0832.863.378. The VAT number is the same number with BE in front: BE 0832.863.378.
Where is DERMA-MED based?
The registered office is at Manoir d'Anjoulaan 42, 1150 Woluwe-Saint-Pierre.Company details
What does DERMA-MED do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DERMA-MED?
DERMA-MED is a private limited company (BV).
When was DERMA-MED founded?
DERMA-MED was founded on 17-01-2011.
Is DERMA-MED still active?
Yes, DERMA-MED is an active enterprise in the KBO register.
What is the turnover of DERMA-MED?
The turnover in financial year 2025 is about €130,000. This figure is estimated from the gross margin of €58,051 and 33 comparable companies (NACE 862). It probably lies between €98,000 and €160,000.Financials
Is DERMA-MED profitable?
In financial year 2025, DERMA-MED made a profit of €22,443.
Where can I find the annual accounts of DERMA-MED?
DERMA-MED filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DERMA-MED due?
DERMA-MED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.